{"url_path":"/sec/ccrn/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","accession_number":"0001628280-26-032542","cik":"0001141103","ticker":"CCRN","issuer_name":"CROSS COUNTRY HEALTHCARE INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","primary_entity_key":"0001141103","primary_entity_name":"CROSS COUNTRY HEALTHCARE INC"},"word_count":264,"has_tables":true,"body_markdown":"ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS\n\n(c) Issuer Purchases of Equity Securities\n\nThe following table sets forth the number of shares purchased, the average price paid per share, the total number of shares purchased as part of publicly announced programs, and the approximate dollar value of shares that may yet be purchased under the programs during each month in the first quarter ended March 31, 2026. See Note 11 - Stockholders’ Equity contained in “Notes to Condensed Consolidated Financial Statements” in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.\n\nPeriodTotal Number of Shares PurchasedAverage Price Paid per Share\nTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs (a)\n\nApproximate Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs (b)\n\n(dollar value in thousands, except per share data)\n\nJanuary 1 through January 31\n260,251 $8.73260,251 $31,700\n\nFebruary 1 through February 28\n225,810 $8.56225,810 $29,767\n\nMarch 1 through March 31\n171,592 $9.45171,592 $28,146\n\nTotal657,653 $8.86657,653 $28,146\n\n________________\n\n(a) Shares were repurchased under the Repurchase Program. The Repurchase Program has no expiration date but may be terminated by the Board of Directors at any time. No shares were purchased other than through publicly announced programs during the periods shown.\n\n(b) On May 1, 2023, the Board of Directors authorized an aggregate of $100.0 million in share repurchases under the Repurchase Program. Amounts shown in this column reflect amounts remaining under the Repurchase Program referenced in Note 11 - Stockholders’ Equity to our condensed consolidated financial statements."}